Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
Pre-Tax Income
Addex Therapeutics Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Addex Therapeutics Ltd
SIX:ADXN
|
Pre-Tax Income
-CHf10.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Pre-Tax Income
-$195.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Pre-Tax Income
-CHf54.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Pre-Tax Income
-$214.8m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Pre-Tax Income
CHf10.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Pre-Tax Income
-CHf820.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-122%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Pre-Tax Income?
Pre-Tax Income
-10.6m
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Pre-Tax Income amounts to -10.6m CHF.
What is Addex Therapeutics Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-45%
Over the last year, the Pre-Tax Income growth was 49%. The average annual Pre-Tax Income growth rates for Addex Therapeutics Ltd have been 6% over the past three years , -45% over the past five years .